Leukaemia UK
LightNews LightNews
banner
leukaemiauk.bsky.social
Leukaemia UK
@leukaemiauk.bsky.social
170 followers 130 following 140 posts
We fund groundbreaking research to stop leukaemia devastating lives by accelerating progress in diagnosis, treatment and care. 🧡
Posts Replies Media Videos
leukaemiauk.bsky.social
📢 A significant step forward in expanding treatment options for B-ALL.

We’re thrilled that Aucatzyl - a CAR-T cell therapy for treating relapsed or refractory B-cell acute lymphoblastic leukaemia - has been approved for use on the NHS in England.

www.leukaemiauk.org.uk/news/leukaem...
An orange graphic which reads, ‘New drug for B-cell acute lymphoblastic leukaemia in England: Aucatzyl' followed by ‘Approved’ with a green tick symbol.
November 25, 2025 at 10:38 AM
leukaemiauk.bsky.social
How incredible is this?! Huge congratulations and a big thank you to Shaun and Salim, who completed the world’s most dangerous dive to raise funds for life-changing leukaemia research in memory of their friend, Trish. 🧡👏
www.express.co.uk/news/uk/2135...
Incredible disabled UK adventurers both survive the 'Diver's Cemetery'
EXCLUSIVE: The two friends took on the world's most dangerous dive site, in Egypt, which requires skill and stamina to survive.
www.express.co.uk
November 24, 2025 at 5:08 PM
leukaemiauk.bsky.social
The recipient of our 2025 Patient Care Pioneer Award: Dr Sarah Stapleton 🏆

Dr Stapleton will look at the psychological support that leukaemia patients might need, and develop a framework to help guide healthcare professionals.

www.leukaemiauk.org.uk/research-and...
November 17, 2025 at 2:58 PM
leukaemiauk.bsky.social
Major breakthrough for T-ALL! Researchers have identified a previously unknown subtype, which can be detected using routine tests. 👏

This means clinicians could soon pinpoint high-risk cases at diagnosis & personalise treatment for children with T-ALL.

bioengineer.org/breakthrough...
An image of a T-cell, a type of lymphocyte which plays a vital role in the body’s immune system. The text on the image reads, ‘Major study uncovers new subtype of T-cell ALL, which can be detected using routine tests at point of diagnosis’.
November 13, 2025 at 5:51 PM
leukaemiauk.bsky.social
This is deeply concerning. Early diagnosis is crucial for successful treatment in all cancers, including leukaemia, which is why we’re calling on the Government to commit to urgently tackling delays in early diagnosis in their upcoming National Cancer Plan.
www.bbc.co.uk/news/article...
Nearly all NHS hospitals are missing cancer targets - is yours one of them?
Experts say patients are being harmed by cancer diagnosis and treatment delays.
www.bbc.co.uk
November 13, 2025 at 10:51 AM
leukaemiauk.bsky.social
Last chance to share your views! How do you want to hear about the impact of your incredible support?

We want to make sure that you’re the first to know about the life-saving research we’re funding, all thanks to you. 🧡

Have your say: https://survey.alchemer.eu/s3/90953656/a60c0b257002
A scientist working in a lab. He is wearing a white lab coat and using a microscope and test tubes. The text on the image reads, ‘Have your say’ alongside an icon of a person holding a tablet and filling out an online survey.
November 6, 2025 at 11:30 AM
leukaemiauk.bsky.social
Promising news! Researchers have found that statins, a cholesterol-lowering drug, could help to tackle “chemo brain” - a debilitating cognitive side effect for many cancer patients. 🤞

www.independent.co.uk/news/health/...
The common drug that can reduce side effects for cancer patients
The common cholesterol-lowering medication protects patients’ mental skills used to plan, organise and manage emotions
www.independent.co.uk
November 5, 2025 at 1:21 PM
leukaemiauk.bsky.social
We want to hear from you - our fantastic supporters!

How can we keep you informed about the impact of your incredible support, and how it’s helping us to fund life-changing leukaemia research?

Fill in our short survey by midnight on Mon 10th Nov: survey.alchemer.eu/s3/90953656/...
A graphic with an icon of a person holding a tablet in their hands and filling out an online survey. The text reads, ‘Share your views. How do you want to hear about the impact of your support?’
October 31, 2025 at 12:05 PM
leukaemiauk.bsky.social
A decade of bold ideas, brilliant minds & real impact. 💡

Our John Goldman Fellowships are driving progress in leukaemia research, from identifying new drug targets to repurposing existing medicines.

Read more: www.leukaemiauk.org.uk/stories/a-de...
A decade of progress and impact - Leukaemia UK
This October marks ten years since Leukaemia UK launched its John Goldman Fellowship (JGF) programme. In this blog, and the next, we’ll explore its impact and successes.
www.leukaemiauk.org.uk
October 30, 2025 at 5:35 PM
leukaemiauk.bsky.social
We’re continuing to fund incredible research and talented scientists who are working hard to find kinder, more effective treatments to stop leukaemia devastating lives. But none of this would be possible without your support. 🧡

Here are a few words from our researchers… 🎥
October 28, 2025 at 3:50 PM
leukaemiauk.bsky.social
Researchers have used gene-editing tools to map mutations in the ABL1 kinase domain - a critical component driving CML - and identify which of these mutations are resistant to certain drugs, opening the door to more personalised treatment options. 👏
scienmag.com/enhanced-res...
Enhanced Resistance Mapping of CML ABL1 Variants
Recent advancements in the realm of precision medicine have brought to light the complexities surrounding the treatment of chronic myeloid leukaemia (CML), particularly when it comes to understanding
scienmag.com
October 23, 2025 at 4:30 PM
leukaemiauk.bsky.social
Thank you @clivejonesmp.bsky.social for leading today's Westminster Hall debate and raising the issues faced by leukaemia patients.

Our thanks also to @drscottarthurmp.bsky.social for echoing our call to ensure the upcoming 10-Year Workforce Plan enables and supports the National Cancer Plan.
Clive Jones, MP for Wokingham, speaking in Westminster Hall. He is wearing a suit with a yellow tie and pocket square, and holding papers in his hands.
October 23, 2025 at 3:07 PM
leukaemiauk.bsky.social
Exciting news! Researchers have now uncovered why proteasome inhibitors, a class of drugs that work well in multiple myeloma, aren’t as effective in AML patients - and how to change this. 👏

Read more: www.technologynetworks.com/tn/news/dual...
An image of red blood cells in the bloodstream. The text on top of the image reads, ‘New study unveils potential dual drug approach for AML using existing multiple myeloma treatment’.
October 22, 2025 at 4:43 PM
leukaemiauk.bsky.social
Thank you Gavin Williamson MP for raising Ruth’s case in Parliament and asking the Government what steps are being taken to support patients with AML.

We welcome @ashleydaltonmp.bsky.social's recommitment to improving AML survival, something we are calling for in the upcoming National Cancer Plan.
October 21, 2025 at 2:33 PM
leukaemiauk.bsky.social
We’re thrilled to have co-supported Molecular Haemopoiesis 2025, bringing together leading researchers exploring blood cell development. 🩸

It was great to see some of our past & present John Goldman Fellows deliver fascinating talks, and see such impactful science in action! 🔬
A lecture theatre filled with people. One person is sitting at the front behind a desk, while another person is stood at a lectern speaking into a microphone. Two screens are visible behind them, with text which reads, ‘AML in Spatial Context: Mapping Tumour-Microenvironment Relationships. Simona Valletta, PhD’.
October 21, 2025 at 10:10 AM
leukaemiauk.bsky.social
We’re delighted to announce our second John Goldman Fellow for 2025 and this year’s Olive Boles Innovation Award winner - Dr Gillian Horne from @uofglasgow.bsky.social 🔬

Her research focuses on building better diagnostic tools to treat Ph+ ALL.

Read more: www.leukaemiauk.org.uk/research-and...
Dr Gillian Horne - Building better diagnostic tools to treat Ph+ ALL: a challenging leukaemia subtype
October 17, 2025 at 9:44 AM
leukaemiauk.bsky.social
⚠️ Last chance to make your voice heard and tell the Government to stop avoidable delays in leukaemia diagnosis.

Join us in demanding better for leukaemia patients ➡️ action.leukaemiauk.org.uk/count-us-in

#CountUsIn
An orange graphic with the text, ‘Diagnose earlier. Diagnose better. Save lives.' in bullet points using the tick symbol. At the bottom is the Leukaemia UK logo and ‘Count Us In’ campaign icon.
October 13, 2025 at 5:11 PM
Reposted by Leukaemia UK
comazzettolab.bsky.social
So humbled to receive the John Goldman Fellowship from @leukaemiauk.bsky.social to identify new metabolic vulnerabilities of B-ALL for future gentler and more targeted therapies. @edinuni-irr.bsky.social @cmvm-edinburghuni.bsky.social @edinburgh-uni.bsky.social
leukaemiauk.bsky.social Leukaemia UK @leukaemiauk.bsky.social · Oct 8
📢 We’re funding two new groundbreaking studies, aimed at developing kinder, more effective treatments for acute lymphoblastic leukaemia (ALL).

Meet @comazzettolab.bsky.social from @edinuni-irr.bsky.social - one of our two new John Goldman Fellows for 2025.

www.leukaemiauk.org.uk/research-and...
October 8, 2025 at 11:30 AM
leukaemiauk.bsky.social
📢 We’re funding two new groundbreaking studies, aimed at developing kinder, more effective treatments for acute lymphoblastic leukaemia (ALL).

Meet @comazzettolab.bsky.social from @edinuni-irr.bsky.social - one of our two new John Goldman Fellows for 2025.

www.leukaemiauk.org.uk/research-and...
October 8, 2025 at 11:14 AM
leukaemiauk.bsky.social
Unfortunately, Tracey’s story isn’t uncommon. A shocking 1 in 4 leukaemia patients experience avoidable delays in their diagnosis. It’s time to change this. 💪

Join us in calling for the Government to commit to taking action ➡️ action.leukaemiauk.org.uk/count-us-in

#CountUsIn
An orange graphic with an image of Tracey, one of Leukaemia UK’s Community Champions. A quote from Tracey reads, ‘I saw my GP several times over months with symptoms including bone pain, exhaustion, bruising and mouth ulcers. I wasn’t offered a full blood count test and was told it was rheumatoid arthritis, but the medication didn’t help. It wasn’t until I fainted and ended up in A&E four months later that I was finally diagnosed with AML. Tracey Palmer-Hole, AML survivor.'
October 6, 2025 at 5:21 PM
leukaemiauk.bsky.social
This month, we’re celebrating a very special milestone: 10 years of our John Goldman Fellowship funding programme. ✨

Over the past decade, our Fellowships have empowered early-career researchers to pursue ideas that push the boundaries of science.

🔗: www.leukaemiauk.org.uk/stories/rese...
An orange graphic with a title at the top which reads, ‘10 years of our John Goldman Fellowships’ followed by four statistics: £6 million of funding, 46 Fellowships awarded, 286 papers published, 27% more global partnerships.
October 3, 2025 at 8:59 AM
leukaemiauk.bsky.social
A fantastic few days at the #Lab25 conference, speaking with MPs and policymakers, including @rthonwesstreeting.bsky.social, about our #CountUsIn campaign and the need for the upcoming National Cancer Plan to stop avoidable delays in leukaemia diagnosis. (1/2)
Wes Streeting, the Secretary of State for Health and Social Care, is stood with members of Leukaemia UK’s Policy & Advocacy team at the Labour Party Conference. He is holding a sign which reads, ‘Let’s stop avoidable delays in diagnosis'.
October 2, 2025 at 11:33 AM
leukaemiauk.bsky.social
Thanks @tobyperkinsmp.bsky.social for taking time at #Lab25 to meet us. We discussed the importance of ensuring that earlier leukaemia diagnosis is prioritised across the NHS.
October 1, 2025 at 5:04 PM
leukaemiauk.bsky.social
Really valuable conversation with @samcarling.bsky.social at #Lab25 about ending avoidable delays in leukaemia diagnosis. Thank you for supporting our Count Us In campaign.
October 1, 2025 at 5:02 PM
leukaemiauk.bsky.social
It was a pleasure to meet @julietcampbellmp.bsky.social at #Lab25 and share how our Count Us In campaign is calling for earlier leukaemia diagnosis to be a priority in the new National Cancer Plan
October 1, 2025 at 5:00 PM